Immune Memory at 17-Years of Follow-Up of a Single Dose of Live Attenuated Hepatitis A Vaccine.

Ying Chen,Chen-Liang Zhou,Xin-Jiang Zhang,Zhi-Yong Hao,Yan-Hong Zhang,Song-Mei Wang,Jing-Chen Ma,Gan Zhao,Chao Qiu,Yu-Liang Zhao,Bin Wang,Xuan-Yi Wang

DOI: https://doi.org/10.1016/j.vaccine.2017.11.036

IF: 4.169

2018-01-01

Vaccine

Abstract:Background: In recent years, hepatitis A virus (HAV) infection has declined considerably in China, associated with wide deployment of HAV vaccines and improvement in socio-economic indicators. Towards the elimination of HA in the country, we assessed the duration and characteristics of immunity conferred by the widely used, locally manufactured HAV vaccine. Methods: This is a longitudinal cohort study that followed recipients of a live attenuated HAV vaccine 17 years after the initial administration. Blood samples were collected from participants pre- and two-week post-booster HAV vaccine dose. Serum anti-HAV antibody was measured by ELISA method. Memory B and T cells were determined by ELISPOT and Flow Cytometry assays, respectively. Results: A robust anamnestic response was observed two-week post-challenge. Both HAV-specific memory B cell and T cells remained, and responded quickly when re-encountering HAV. The magnitude of recall responses was present, regardless of the status of the serum anti-HAV antibody pre-booster. Conclusions: We demonstrated long-term immunity from the live attenuated HAV vaccine, including antibody persistence and immunological memory. Considering the conditions that make elimination of infectious diseases feasible, following polio, hepatitis A could be targeted for elimination in China. (C) 2017 Elsevier Ltd. All rights reserved.